May 2, 2013
Daiichi Sankyo announced on April 26 that it has entered into a clinical trial agreement with Perosphere Inc. of the US to evaluate the anticoagulant reversal agent PER977, which has been discovered by Perosphere. The Japanese company plans to determine...read more